Latest Breaking News On - Antengene corporation - Page 1 : comparemela.com

Antengene To Present One Oral and Four Abstracts at ASCO 2024

/PRNewswire/ Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated.

United statesSouth koreaHong kongMccormick placeAsia pacificPeter qianAntengene corporation limitedPrnewswire antengene corporation limitedMccormick place convention centerHong kong stock exchangeCompany annualAntengene corporationAmerican society of clinical oncologyOral presentationCorporation limitedClinical oncology

Antengene Presents Four Preclinical Posters At AACR 2024

Antengene Presents Four Preclinical Posters At AACR 2024
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

San diegoUnited statesHong kongSouth koreaSan diego convention centerAsia pacificPeter qianAntengene corporation limitedPrnewswire antengene corporation limitedAmerican association for cancer research annual meetingAntengene corporationCompany annualHong kong stock exchangeClinical researchCorporation limitedCancer research annual meeting

Antengene Presents Four Preclinical Posters at AACR 2024

Antengene Presents Four Preclinical Posters at AACR 2024
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSan diego convention centerHong kongSouth koreaSan diegoPeter qianAsia pacificHong kong stock exchangeClinical researchPrnewswire antengene corporation limitedAntengene corporationAntengene corporation limitedAmerican association for cancer research annual meetingCompany annualCorporation limitedCancer research annual meeting

Antengene Announces Inclusion of XPOVIO® (selinexor) in 2023 China s National Reimbursement Drug List

Antengene Announces Inclusion of XPOVIO® (selinexor) in 2023 China s National Reimbursement Drug List
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Hong kongSouth koreaAsia pacificJay meiPeter qianKaryopharm therapeutics incPrnewswire antengene corporation limitedNational reimbursement drug listCompany annualAntengene corporationAntengene corporation limitedHong kong stock exchangeNational healthcare security administrationCorporation limitedHong kong chinaMacau china

Antengene Announces XPOVIO® Regulatory Approval in Macau for the Treatment of Relapsed and/or Refractory Multiple Myeloma

Antengene Announces XPOVIO® Regulatory Approval in Macau for the Treatment of Relapsed and/or Refractory Multiple Myeloma
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Hong kongSouth koreaPeter qianAsia pacificJay meiPrnewswire antengene corporation limitedNational cancer care networkAntengene corporationInternational myeloma working groupEuropean society of medical oncologyAntengene corporation limitedCompany annualChinese society of clinical oncologyAdministration bureau of macauKaryopharm therapeutics incHong kong stock exchange